There are significant mental health disparities between Indigenous and non-Indigenous people in Canada, largely due to a legacy of colonization. Though Indigenous health is legally a federal responsibility, mental health services vary dramatically between provinces and territories.
Gustavo Betini, a PhD student in the school of Public Health Science at the University of Waterloo, has spent the past year immersed in studying the mental health effects of COVID-19. His research has shown that, even though fear of contracting the virus is waning, almost a quarter of Canadians continue to report having high anxiety and depression related to the pandemic.
Negin Ashouri is on a mission to elevate women’s quality of life, one medical device at a time. Through her business FemTherapeutics, she created an innovative, made-to-measure, biodegradable, and disposable intravaginal prosthetic called a pessary to help women suffering from pelvic organ prolapse (POP).
For Toronto-based Dose Biosystems, a focus on researching and developing the next generation of probiotics brings a hiring challenge: finding and onboarding highly specialized talent. Coming directly from doctoral programs, new employees encounter an unfamiliar environment that requires new skills and different ways of working.
Gum disease is a condition that shows up in 85 percent of cats and dogs before the age of four. Without proper treatment, the illness is painful and can lead to other health issues such as heart or kidney disease.
To improve the health of pets and prevent the issue, Quebec entrepreneur Andrée-Ann Adam has been working on a first-of-its-kind, all-natural dental gel.
As of July 27, 2020, the number of COVID-19 confirmed cases worldwide reached 16.3 million people, with 114,000 cases in Canada. About two to eight percent of COVID-19 cases experience severe symptoms that lead to respiratory distress, organ failure, and even death. Currently, regular medical checkups consist of one-on-one phone calls to monitor the patient’s vital signs remotely.
When the second wave of the Spanish flu hit Canada over 100 years ago, the effect was even more devastating than that of its first wave. In fact, 90 percent of the deaths happened in the fall of 1918, during the pandemic’s second peak.
When Gurudeeban Selvaraj and Satyavani Kaliamurthi came to Canada in 2019, they had no idea they would be creating both a preventative vaccine and a curing drug to address the millennium’s biggest pandemic.
As of May 27, 2020, there have been 2,925,466 infected COVID-19 patients reported worldwide, with a total of 355,727 deaths. The rapid progression of the COVID-19 pandemic has raised concerns regarding the short supply of medical equipment needed to control the rate of transmission and mortality. In most developing countries, transporting vaccines can be difficult without the proper storage technologies, since vaccines and equipment can spoil in high temperatures.